Advisory Services Network’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.91M Buy
38,689
+6,796
+21% +$1.04M 0.08% 266
2025
Q4
$4.4M Buy
31,893
+41
+0.1% +$5.37K 0.06% 334
2025
Q3
$4.08M Sell
31,852
-250
-0.8% -$30.5K 0.06% 346
2025
Q2
$3.65M Buy
32,102
+747
+2% +$84.2K 0.06% 352
2025
Q1
$3.5M Sell
31,355
-3,524
-10% -$375K 0.07% 332
2024
Q4
$3.39M Sell
34,879
-172
-0.5% -$18.3K 0.06% 337
2024
Q3
$3.73M Hold
35,051
0.08% 284
2024
Q2
$3.73M Sell
35,051
-2,070
-6% -$208K 0.08% 284
2024
Q1
$3.59M Buy
37,121
+2,491
+7% +$255K 0.08% 294
2023
Q4
$3.5M Sell
34,630
-1,610
-4% -$155K 0.09% 267
2023
Q3
$3.69M Sell
36,240
-4,266
-11% -$433K 0.1% 236
2023
Q2
$4.09M Buy
40,506
+4,472
+12% +$447K 0.11% 217
2023
Q1
$3.32M Buy
36,034
+1,936
+6% +$169K 0.09% 257
2022
Q4
$3.09M Sell
34,098
-1,911
-5% -$161K 0.09% 256
2022
Q3
$2.74M Sell
36,009
-13,225
-27% -$1.1M 0.1% 256
2022
Q2
$4.16M Buy
49,234
+4,108
+9% +$360K 0.14% 179
2022
Q1
$3.96M Buy
45,126
+8,271
+22% +$716K 0.12% 211
2021
Q4
$3.22M Buy
36,855
+627
+2% +$52.1K 0.09% 266
2021
Q3
$2.96M Buy
36,228
+5,753
+19% +$518K 0.09% 278
2021
Q2
$2.78M Sell
30,475
-419
-1% -$37.3K 0.09% 293
2021
Q1
$2.64M Buy
30,894
+5,794
+23% +$520K 0.1% 269
2020
Q4
$2.37M Buy
25,100
+344
+1% +$30.1K 0.1% 252
2020
Q3
$2.15M Sell
24,756
-132
-0.5% -$11.4K 0.1% 231
2020
Q2
$2.17M Buy
24,888
+3,452
+16% +$298K 0.12% 218
2020
Q1
$1.77M Buy
21,436
+2,312
+12% +$206K 0.12% 215
2019
Q4
$1.81M Buy
19,124
+2,827
+17% +$254K 0.1% 265
2019
Q3
$1.49M Hold
16,297
0.09% 292
2019
Q2
$1.49M Sell
16,297
-930
-5% -$78.7K 0.09% 292
2019
Q1
$1.48M Buy
17,227
+897
+5% +$72K 0.1% 262
2018
Q4
$1.26M Buy
16,330
+3,611
+28% +$281K 0.11% 250
2018
Q3
$982K Buy
12,719
+1,596
+14% +$118K 0.07% 346
2018
Q2
$830K Sell
11,123
-4,801
-30% -$331K 0.06% 386
2018
Q1
$1.15M Sell
15,924
-2,012
-11% -$153K 0.09% 299
2017
Q4
$1.35M Buy
17,936
+850
+5% +$64.1K 0.12% 225
2017
Q3
$1.31M Sell
17,086
-154
-0.9% -$11.6K 0.15% 174
2017
Q2
$1.29M Buy
17,240
+10,378
+151% +$736K 0.17% 157
2017
Q1
$457K Buy
+6,862
New +$457K 0.07% 370
2016
Q3
$416K Buy
5,879
+474
+9% +$34.5K 0.08% 345
2016
Q2
$400K Buy
5,405
+399
+8% +$27.6K 0.09% 300
2016
Q1
$325K Buy
5,006
+991
+25% +$67.4K 0.09% 283
2015
Q4
$310K Buy
4,015
+3,307
+467% +$263K 0.1% 254
2015
Q3
$58K Sell
708
-5,139
-88% -$457K 0.02% 503
2015
Q2
$516K Sell
5,847
-107
-2% -$9.82K 0.15% 157
2015
Q1
$535K Buy
5,954
+48
+0.8% +$4.26K 0.15% 156
2014
Q4
$537K Sell
5,906
-96
-2% -$7.96K 0.17% 136
2014
Q3
$506K Sell
6,002
-5,899
-50% -$477K 0.19% 137
2014
Q2
$965K Sell
11,901
-531
-4% -$41.8K 0.41% 65
2014
Q1
$947K Buy
12,432
+395
+3% +$28.8K 0.49% 52
2013
Q4
$867K Buy
+12,037
New +$837K 0.44% 55

Other funds holding NVS

Advisory Services Network's NVS Position: Q1 2026 in Review

Advisory Services Network increased its Novartis (NVS) stake by 21% in Q1 2026, buying an estimated $1.04M and bringing the position to 38,689 shares worth $5.91M. The position accounts for 0.08% of the portfolio, ranked #266.

Advisory Services Network first reported a position in NVS in Q4 2013 and has held it in 49 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Advisory Services Network held 38,689 shares of Novartis worth $5.91M as of Q1 2026.
  • Advisory Services Network bought 6,796 Novartis shares in Q1 2026, an estimated $1.04M.
  • Novartis made up 0.08% of Advisory Services Network's portfolio in Q1 2026, its #266 holding.
  • Advisory Services Network first reported a position in Novartis in Q4 2013 and has held it in 49 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.